Skip to main content

Clinical Trials Using Pidnarulex

Review the clinical trials studying pidnarulex on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 1-4 of 4

Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation
Status: Active
Location: 6 locations
Testing the Safety of Anti-Cancer Drug, CX-5461 (Pidnarulex), in Treating Lymphoma with Specific Changes in the MYC Gene
Status: Active
Location: Yale University Cancer Center LAO, New Haven, Connecticut
Testing How the Body Responds to the Drug CX-5461 (Pidnarulex) in Patients with Metastatic Solid Cancers
Status: Active
Location: National Cancer Institute Developmental Therapeutics Clinic, Bethesda, Maryland
Testing the Safety of the Combination of Anti-Cancer Drugs CX-5461 (Pidnarulex) and Trastuzumab Deruxtecan (T-DXd) for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Solid Tumors and Breast Cancer
Status: Active
Location: Dana-Farber - Harvard Cancer Center LAO, Boston, Massachusetts